✦ LIBER ✦

Optimal dosage of telaprevir in triple therapy for chronic hepatitis C in view of virological response and anemic severity

✍ Scribed by Masumoto, A.; Yada, M.; Suzuki, H.; Senjyu, T.; Koyanagi, T.; Motomura, K.

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Therapeutic drug monitoring of telaprevi

✍ Furusyo, N.; Ogawa, E.; Murata, M.; Toyoda, K.; Ohnishi, H.; Eiraku, K.; Shimizu 📂 Article 📅 2013 🏛 Oxford University Press 🌐 English ⚖ 275 KB

Virological response rates for telaprevi

✍ Martel-Laferrière, V; Brinkley, S; Bichoupan, K; Posner, S; Stivala, A; Perumals 📂 Article 📅 2013 🏛 John Wiley and Sons 🌐 English ⚖ 117 KB

Telaprevir or boceprevir triple therapy

✍ Saxena, V.; Manos, M. M.; Yee, H. S.; Catalli, L.; Wayne, E.; Murphy, R. C.; Shv 📂 Article 📅 2014 🏛 John Wiley and Sons 🌐 English ⚖ 248 KB

820 THERAPEUTIC DRUG MONITORING OF TELAP

✍ Furusyo, N.; Ogawa, E.; Murata, M.; Toyoda, K.; Ohnishi, H.; Eiraku, K.; Shimizu 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 60 KB

Effectiveness and safety of reduced-dose

✍ Sezaki, Hitomi; Suzuki, Fumitaka; Hosaka, Tetsuya; Akuta, Norio; Fukushima, Tait 📂 Article 📅 2014 🏛 John Wiley and Sons 🌐 English ⚖ 357 KB

Factors associated with sustained virolo

✍ Abe, Hiroshi; Tsubota, Akihito; Shimada, Noritomo; Atsukawa, Masanori; Kato, Kei 📂 Article 📅 2014 🏛 John Wiley and Sons 🌐 English ⚖ 626 KB